Mera Pharmaceuticals, Inc.

OTCPK:MRPI Stock Report

Market Cap: US$536.0

Mera Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Benny Doro

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure8.2yrs
Board average tenure12.6yrs

Recent management updates

Recent updates

CEO

Benny Doro (56 yo)

3.8yrs

Tenure

Mr. Benny Doro is Founder of Food Culture Inc. (formerly known as Golden Star Enterprises Ltd.) and serves as its Chief Executive Officer & Director and served as its President. He serves as Chief Executiv...

Leadership Team

NamePositionTenureCompensationOwnership
Benny Doro
CEO, Interim Director3.8yrsno datano data
Lawrence Wolfe
Chief Financial Officer12.6yrsno datano data
Melanie Kelekolio
General Manager of The Operations & Production Facility and Vice Presidentno datano datano data
Joyce Markley
Secretary and Director12.6yrsno datano data
Rafi Markarians
Treasurer & Director3.8yrsno datano data

8.2yrs

Average Tenure

58yo

Average Age

Experienced Management: MRPI's management team is seasoned and experienced (8.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lawrence Wolfe
Chief Financial Officer12.6yrsno datano data
Joyce Markley
Secretary and Director12.6yrsno datano data
Rafi Markarians
Treasurer & Director3.8yrsno datano data
Fred Villari
Director12.6yrsno datano data

12.6yrs

Average Tenure

61yo

Average Age

Experienced Board: MRPI's board of directors are seasoned and experienced ( 12.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 23:07
End of Day Share Price 2024/11/15 00:00
Earnings2021/07/31
Annual Earnings2020/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mera Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution